Cargando…
A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer’s disease mice
Many Alzheimer’s disease (AD) patients suffer from cerebrovascular abnormalities such as altered cerebral blood flow and cerebral microinfarcts. Recently, fibrinogen has been identified as a strong cerebrovascular risk factor in AD, as it specifically binds to β-amyloid (Aβ), thereby altering fibrin...
Autores principales: | Ahn, Hyung Jin, Glickman, J. Fraser, Poon, Ka Lai, Zamolodchikov, Daria, Jno-Charles, Odella C., Norris, Erin H., Strickland, Sidney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042638/ https://www.ncbi.nlm.nih.gov/pubmed/24821909 http://dx.doi.org/10.1084/jem.20131751 |
Ejemplares similares
-
Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke
por: Chen, Zu-Lin, et al.
Publicado: (2013) -
Striatal fibrinogen extravasation and vascular degeneration correlate with motor dysfunction in an aging mouse model of Alzheimer’s disease
por: Berk-Rauch, Hanna E., et al.
Publicado: (2023) -
A novel detection method of cleaved plasma high-molecular-weight kininogen reveals its correlation with Alzheimer's pathology and cognitive impairment
por: Yamamoto-Imoto, Hitomi, et al.
Publicado: (2018) -
The contact activation system and vascular factors as alternative targets for Alzheimer's disease therapy
por: Singh, Pradeep K., et al.
Publicado: (2021) -
A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer’s disease
por: Chen, Zu-Lin, et al.
Publicado: (2023)